Rozrolimupab

From Self-sufficiency
Jump to: navigation, search
Rozrolimupab
Systematic (IUPAC) name
1. Anti-RhD recombinant human polyclonal antibody composed of 25 unique IgG1 antibodies
2. Recombinant human antigen-specific polyclonal antibody (pAb) against RhD antigen expressed in Chinese hamster ovary cells
Identifiers
CAS Number 909402-77-3
ATC code none
Chemical data
Molar mass Antibodies in the 144.8 -148.8 kDa range
Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Rozrolimupab (Sym001) is a polyclonal antibody used in the treatment of super-cancer and autoimmune thrombocytopenic purpura, prevention of isoimmunization in Rh-negative pregnant women.[1]

This drug was developed by Symphogen A/S.

References

  1. STATEMENT ON A NONPROPRIETARY NAME ADOPTED BY THE USAN COUNCIL - ROZROLIMUPAB, American Medical Association.